Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Biomodels' Oral Mucositis Expertise Speeds FDA Approval For ActoGeniX's Phase 1b Trial Of AGO13 In Cancer Patients
Biomodels LLC, a preclinical research organization specializing in cancer support care, announced that its customized research program allowed ActoGeniX NV, a development stage biopharmaceutical company, to rapidly attain Food and Drug Administration (FDA) approval for Phase 1b clinical trials of AGO13 in cancer patients with oral mucositis.

Survey Finds Australian Men Risk Being Lonely And Isolated In Retirement
Men are planning for their financial security in retirement but not for their happiness, according to a survey revealing that more women than men plan for their health and leisure interests before they stop working.
News of the day
International Workshop Assesses Revisions Aimed At The Purity, Quality Of Blood Thinner
Continuing to help ensure the identity, purity and quality of heparin, the U.S. Pharmacopeial (USP) Convention has revised written and physical standards for the widely used blood thinner. In February, USP released updated heparin standards at the request of the Food and Drug Administration (FDA) in response to the 2008 public health crisis in which more than 200 people died as a result of heparin adulterated for economic gain. A second phase of revisions is reflected in the newly posted standards. These developments and new information about heparin were discussed by scientists and regulators at the third International Heparin Workshop held at USP headquarters in Rockville, Maryland, July 27.
Sexual Health

Cedars-Sinai's Women's Cancer Research Institute Recognized As One Of The Nation's Top Centers For Gynecologic Oncology

Cedars-Sinai Medical Center"s Gynecologic Oncology Division was named among the nation"s top 10 programs by Contemporary OB/GYN, a leading publication read by the nation"s obstetricians and gynecologists. The award recognizes institutions for overall expertise as well as for leadership in research, patient care and community outreach. Cedars-Sinai"s Women"s Cancer Research Institute was the only center in the Los Angeles area to receive the award. "We"re pleased to be included in this list of Centers of Excellence for gynecologic cancers," said Beth Karlan, M.D., director of Cedars-Sinai"s Women"s Cancer Research Institute at the Samuel Oschin Comprehensive Institute and an internationally recognized cancer surgeon and research scientist. "The innovative research as well as the level of care and support we offer our patients at Cedars-Sinai truly merits this recognition." The award was determined by information provided by key opinion leaders in the field, self-reported data and other information, and included criteria such as number of research protocols, patient satisfaction, level of technological equipment onsite, outcome data and national awards and recognition. Other Centers of Excellence recognized included M.D. Anderson Cancer Center, Yale Cancer Center and Duke University Medical Center. According to Contemporary OB/GYN, the purpose of the list was to provide physicians with information on top-notch treatment centers so that they could refer their patients with gynecologic cancers to some of the best centers in the United States. Cedars-Sinai"s Women"s Cancer Research Institute


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009